Influenza
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) According to the diagnosis of influenza; (2) Flu rapid antigen test results are positive; (3) Body temperature (under axilla) 37.8 to 39.0 degree C at the time of consultation; (4) The course of influenza is within 48 hours; (5) TCM syndrome differentiation is wind-cold and internal heat syndrome; (6) Aged 18-65 years old; (7) Those who voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Severe flu patients or critically ill patients; (2) The total number of white blood cells in blood routine examination > 11.0 *10^9/L, or the percentage of neutrophils > 80%, or CRP exceeding the upper limit of reference value; (3) Patients with acute episodes of upper respiratory tract diseases such as sinusitis, allergic rhinitis, chronic pharyngitis, tonsillitis, herpes angina were diagnosed; (4) Complicated with lower respiratory tract infection (such as pneumonia, acute, chronic bronchitis, bronchiectasis); (5) During the course of the disease, those who had taken antiviral drugs,antibiotics or traditional Chinese medicine for treating influenza before admission to the group; (6) Patients who have received influenza vaccine within 1 year; (7) Patients with BMI >30; (8) Patients complicated with serious primary diseases such as heart, lung, brain and hematopoietic system or malignant tumors; (9) Drug allergies to test drugs, including those who have allergic history to the ingredients of the product, paracetamol or pharmaceutical excipients; (10) Women in pregnancy or planned pregnancy, breast-feeding women, who are unable or unwilling to take adequate contraception during the trial or whose spouses are unwilling to take contraceptive measures; (11) Psychiatric subjects and those unable to cooperate with clinical trials; (12) Those who have participated in other clinical trials within four weeks or are participating in other drug clinical trials at present; (13) Doctors do not consider it appropriate for the patient to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3 days antipyretic rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset time of antipyretic;Body temperature recovery time;Improvement of main clinical symptoms (cough, headache, joint soreness);Clinical curative effect of influenza;TCM syndrome curative effect;Administration of paracetamol tablets; | — |
Countries
China
Contacts
Beijing hospital of Traditional Chinese Medicine affiliated to Capital Medical University